Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Daley

Showing results (111-120 of 230) with videos related to

Pageof 23
Sort By:
The Lancet. Infectious Diseases|July 30, 2011
XDR tuberculosisJakko van Ingen, Wiel Cm de Lange, Martin J Boeree, et al.
Chest|August 28, 2020
Development of Drugs for Nontuberculous Mycobacterial Disease: Clinicians' Interpretation of a US Food and Drug Administration WorkshopPatrick A Flume, David E Griffith, James D Chalmers, et al.
BMC Infectious Diseases|January 5, 2011
Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosisPayam Nahid, Leah G Jarlsberg, Irina Rudoy, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 25, 2021
Pharmacokinetics of oral antimycobacterials and dosing guidance for Mycobacterium avium complex treatment in cystic fibrosisStacey L Martiniano, Brandie D Wagner, Laney Brennan, et al.
American Journal of Respiratory and Critical Care Medicine|February 10, 2007
Treatment outcomes of patients with HIV and tuberculosisPayam Nahid, Leah C Gonzalez, Irina Rudoy, et al.
Respiratory Medicine|March 17, 2023
Towards development of evidence to inform recommendations for the evaluation and management of bronchiectasisPatrick A Flume, Ashwin Basavaraj, Bryan Garcia, et al.
The Journal of Antimicrobial Chemotherapy|March 13, 2025
Pharmacodynamic assessment of apramycin against Mycobacterium abscessus in a hollow fibre infection modelNidhi Singh, Bikash Dangi, Jeremy J Johnson, et al.
Annals of Internal Medicine|October 16, 2002
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trialRobert M Jasmer, Jussi J Saukkonen, Henry M Blumberg, et al.
Respiratory Medicine|March 5, 2019
Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary diseaseSeong Mi Moon, Junsu Choe, Byung Woo Jhun, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2003
Yield of sputum induction in the diagnosis of pleural tuberculosisMarcus B Conde, Angela Chindamo Loivos, Valeria M Rezende, et al.
Pageof 23

Showing results (111-120 of 230) with videos related to

Sort By:
Pageof 23
The Lancet. Infectious Diseases|July 30, 2011
XDR tuberculosisJakko van Ingen, Wiel Cm de Lange, Martin J Boeree, et al.
Chest|August 28, 2020
Development of Drugs for Nontuberculous Mycobacterial Disease: Clinicians' Interpretation of a US Food and Drug Administration WorkshopPatrick A Flume, David E Griffith, James D Chalmers, et al.
BMC Infectious Diseases|January 5, 2011
Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosisPayam Nahid, Leah G Jarlsberg, Irina Rudoy, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 25, 2021
Pharmacokinetics of oral antimycobacterials and dosing guidance for Mycobacterium avium complex treatment in cystic fibrosisStacey L Martiniano, Brandie D Wagner, Laney Brennan, et al.
American Journal of Respiratory and Critical Care Medicine|February 10, 2007
Treatment outcomes of patients with HIV and tuberculosisPayam Nahid, Leah C Gonzalez, Irina Rudoy, et al.
Respiratory Medicine|March 17, 2023
Towards development of evidence to inform recommendations for the evaluation and management of bronchiectasisPatrick A Flume, Ashwin Basavaraj, Bryan Garcia, et al.
The Journal of Antimicrobial Chemotherapy|March 13, 2025
Pharmacodynamic assessment of apramycin against Mycobacterium abscessus in a hollow fibre infection modelNidhi Singh, Bikash Dangi, Jeremy J Johnson, et al.
Annals of Internal Medicine|October 16, 2002
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trialRobert M Jasmer, Jussi J Saukkonen, Henry M Blumberg, et al.
Respiratory Medicine|March 5, 2019
Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary diseaseSeong Mi Moon, Junsu Choe, Byung Woo Jhun, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2003
Yield of sputum induction in the diagnosis of pleural tuberculosisMarcus B Conde, Angela Chindamo Loivos, Valeria M Rezende, et al.
Pageof 23